Corporate Sponsors |
Biomarker World Congress 2010 : 2010年5月4-6日 Philadelphia, PA
DISTINGUISHED FACULTY: John L. Allinson, FIBMS, Vice President, Biomarker Laboratory Services, ICON Development Solutions Michael Amos, Ph.D., Scientific Advisor, Chemical Science & Technology Laboratory, National Institute of Standards & Technology Measurement; Ex-Officio Member, Secretary's Advisory Committee on Genetics Health and Society (SACGHS), Department of Health and Human Services Massimo Cristofanilli, M.D., FACP, Professor and Chairman, Department of Medical Oncology; G. Morris Dorrance Jr. Endowed Chair in Medical Oncology, Fox Chase Cancer Center (FCCC) Viswanath Devanarayan, Ph.D., Director, Global Exploratory Statistics, Abbott Laboratories Giora Feuerstein, M.D., Assistant Vice President and Head, Discovery Translational Medicine, Wyeth Research Mark Fidock, Ph.D., Head, Quantitative Biomarkers, Research Enabling Group, Pfizer Ltd. Felix W. Frueh, Ph.D., Vice President, Research & Development, Personalized Medicine, Medco Health Solutions, Inc. Andrew Grupe, Ph.D., Senior Director, Pharmacogenomics Research & Development, Celera Corporation Darren Hodgson, M.D., Biomics Advisor, Oncology and Infection Therapy Area, AstraZeneca Dave S.B. Hoon, Ph.D., Director, Department of Molecular Oncology, John Wayne Cancer Institute Pearl S. Huang, Ph.D., Vice President, Integrator Oncology Franchise, Research and Early Development, Merck and Co. Francis Kalush, Ph.D., Network Leader, Diagnostics & Personalized Medicine, CDRH, U.S. Food and Drug Administration Aaron B. Kantor, Ph.D., Chief Scientific Officer, Research and Development, Immune Tolerance Institute Joe Keenan, Head, Sales and Marketing, Argutus Medical Ltd. Geert J.C.M. Kolvenbag, M.D., Ph.D., Global Product Vice President, Oncology, AstraZeneca Pharmaceuticals, Inc. Myla Lai-Goldman, M.D., Chief Executive Officer, CancerGuide Diagnostics, Inc. Thomas M. Li, Ph.D., CTO and Senior Director, Technology Management, Roche Diagnostics Robert McCormack, Ph.D., Director, Technology Assessment, Ortho Clinical Diagnostics, Veridex, LLC Glenn A. Miller, Ph.D., Vice President and General Manager, Genzyme Analytical Services Madhu Mondal, Ph.D., DABT, Head, Protein and Analytical Toxicology Laboratory, Investigative Toxicology/Preclinical Safety, Novartis Institutes of Biomedical Research, Inc. Margaret Piper, Ph.D., MPH, Director, Genomics Resources, Technology Evaluation Center, Blue Cross Blue Shield Association Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag; Former California Medical Director, NHIC Donna Roscoe, Ph.D., Scientific Reviewer, DIHD/OIVD/CDRH/FDA Allen D. Roses, M.D., Jefferson-Pilot Professor of Neurobiology and Neurology, Director, Deane Drug Discovery Institute, Duke University Yaping Shou, M.D., Ph.D., Director, Oncology Biomarkers and Imaging, Biomarker Project Leader-Tasigna, Novartis Institutes for BioMedical Research Alain Van Gool, Ph.D., Head, Molecular Profiling Technologies, Schering Plough John Wagner, M.D., Ph.D., Vice President, Clinical Pharmacology, Merck Research Labs Yaning Wang, Ph.D., Team Leader, Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration David Wholley, Director, The Biomarkers Consortium, Foundation for the National Institutes of Health Hans Winkler, Ph.D., Senior Director and Global Head, Oncology Biomarkers, Johnson & Johnson Pharmaceutical R&D |
Choose your language  
市场情报数据 产业会议汇总历 |
.jpg "Caprion")
_resized(1).jpg "febit (New Logo)")
(1).jpg "Millipore (updated)")
